Atossa Therapeutics
ATOS
#9237
Rank
HK$0.80 B
Marketcap
HK$6.22
Share price
5.24%
Change (1 day)
-34.44%
Change (1 year)

Atossa Therapeutics (ATOS) - Cash on Hand

Cash on Hand as of June 2025 : HK$0.45 Billion

According to Atossa Therapeutics's latest financial reports the company has HK$0.45 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Atossa Therapeutics - Cash on Hand chart (from 2010 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$0.55 B-20.12%
2023-12-31HK$0.69 B-20.26%
2022-12-31HK$0.86 B-18.53%
2021-12-31HK$1.06 B246.81%
2020-12-31HK$0.30 B212.94%
2019-12-31HK$97.98 M20.54%
2018-12-31HK$81.28 M44.15%
2017-12-31HK$56.38 M140.16%
2016-12-31HK$23.48 M-18.47%
2015-12-31HK$28.8 M-56.32%
2014-12-31HK$65.93 M34.07%
2013-12-31HK$49.17 M267.77%
2012-12-31HK$13.37 M-9.9%
2011-12-31HK$14.84 M18500.06%
2010-12-31HK$0.07 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
HK$144.49 B 31,982.55%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$4.65 B 933.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$3.36 B 646.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
HK$0.28 B-36.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
HK$1.27 B 183.66%๐Ÿ‡บ๐Ÿ‡ธ USA